Justice News

Justice News

Email Updates Email updates Press releases and speeches before January 20, 2009

January 31, 2018

Press Release
Attorney General Sessions Announces DEA Surge to Combat Prescription Drug Diversion

February 27, 2018

Press Release
Attorney General Sessions Announces New Prescription Interdiction & Litigation Task Force

March 1, 2018

Press Release
Attorney General Sessions Takes Further Action to Combat Opioid Crisis - Directs the DEA to Evaluate Aggregate Production Quotas

March 21, 2018

Press Release
Attorney General Sessions Issues Memo to U.S. Attorneys on the Use of Capital Punishment in Drug-Related Prosecutions

April 2, 2018

Press Release
DEA Surge in Drug Diversion Investigations Leads to 28 Arrests and 147 Revoked Registrations

April 17, 2018

Press Release
Attorney General Sessions Announces Changes in DEA Opioid Limit Rules
Press Release
DEA to Share Painkiller Prescription Information with 48 Attorneys General

May 4, 2018

Press Release
DEA Suspends the Registration of Morris & Dickson Company from Distributing Controlled Substances

May 7, 2018

Press Release
DEA Brings in Record Number of Unused Pills During 15th Annual National Prescription Drug Take Back Day

June 26, 2018

Press Release
First Nationwide Undercover Operation Targeting Darknet Vendors Results in Arrests of More Than 35 Individuals Selling Illicit Goods and the Seizure of Weapons, Drugs and More Than $23.6 Million
Press Release
Department of Justice Announces $110 Million Set Aside Grant Program to Assist Crime Victims in Indian Country

August 1, 2018

Press Release
Michigan Physician Pleads Guilty to Conspiracy to Distribute Controlled Substances

August 22, 2018

Press Release
Justice Department Takes First-of-its-Kind-Legal Action to Reduce Opioid Over-Prescription

August 28, 2018

Press Release
Co-Owners of Miami Pain Management Clinic Plead Guilty to Conspiracy to Distribute Medically Unnecessary Opioid Prescriptions

August 31, 2018

Press Release
District Court Enters Permanent Injunction to Stop New Jersey and New York Companies and Executives From Distributing Unapproved and Misbranded Drugs

September 27, 2018

Press Release
FDA-Approved Drug Epidiolex Placed in Schedule V of Controlled Substances Act
Subscribe to News
Para Noticias en Español
Offices of the United States Attorneys News

Was this page helpful?

Was this page helpful?
Yes No